iRhythm Technologies (LTS:0A7L) Retained Earnings : $-691.3 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is iRhythm Technologies Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. iRhythm Technologies's retained earnings for the quarter that ended in Mar. 2024 was $-691.3 Mil.

iRhythm Technologies's quarterly retained earnings declined from Sep. 2023 ($-606.9 Mil) to Dec. 2023 ($-645.6 Mil) and declined from Dec. 2023 ($-645.6 Mil) to Mar. 2024 ($-691.3 Mil).

iRhythm Technologies's annual retained earnings declined from Dec. 2021 ($-406.0 Mil) to Dec. 2022 ($-522.2 Mil) and declined from Dec. 2022 ($-522.2 Mil) to Dec. 2023 ($-645.6 Mil).

iRhythm Technologies Retained Earnings Historical Data

The historical data trend for iRhythm Technologies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies Retained Earnings Chart

iRhythm Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

-260.39

-304.68

-406.05

-522.20

-645.61

iRhythm Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Retained Earnings	Get a 7-Day Free Trial															-561.31	-579.79	-606.91	-645.61	-691.27

iRhythm Technologies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

iRhythm Technologies (LTS:0A7L) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

iRhythm Technologies (LTS:0A7L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (LTS:0A7L) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

IRTC:USA

Address

699 8th Street, Suite 600, San Francisco, CA, USA, 94103

Website

https://www.irhythmtech.com

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

iRhythm Technologies (LTS:0A7L) Headlines

No Headlines